The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Treatment strategies for autoimmune encephalitis
Open accessAbstract
Autoimmune encephalitis is one of the most rapidly growing research topics in neurology. Along with discoveries of novel antibodies associated with the disease, clinical experience and outcomes with diverse immunotherapeutic agents in the treatment of autoimmune encephalitis are accumulating. Retrospective observations indicate that early aggressive treatment is associated with better functional outcomes and fewer relapses. Immune response to first-line immunotherapeutic agents (corticosteroids, intravenous immunoglobulin, plasma exchange, and immunoadsorption) is fair, but approximately half or more of patients are administered second-line immunotherapy (rituximab and cyclophosphamide). A small but significant proportion of patients are refractory to all first- and second-line therapies and require further treatment. Although several investigations have shown promising alternatives, the low absolute number of patients involved necessitates more evidence to establish further treatment strategies. In this review, the agents used for first- and second-line immunotherapy are discussed and recent attempts at finding new treatment options are introduced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coiffier, B., Lepage, E., Brière, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011795 · Cited by 5,574
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
Titulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., Honig, L. S., Benseler, S. M., Kawachi, I., Martinez-Hernandez, E., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70310-1 · Cited by 3,165
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21050 · Cited by 2,492
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M. R., & Balice-Gordon, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70253-2 · Cited by 2,435
Smolen, J. S., Beaulieu, A., Rubbert-Roth, A., Ramos-Remus, C., Rovensky, J., Alecock, E., Woodworth, T., & Alten, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60453-5 · Cited by 1,399
Lai, M., Huijbers, M. G., Lancaster, E., Graus, F., Bataller, L., Balice-Gordon, R., Cowell, J. K., & Dalmau, J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70137-x · Cited by 1,361
Jayne, D., Rasmussen, N., Andrassy, K., Bacon, P., Tervaert, J. W. C., Dadoniené, J., Ekstrand, A., Gaskin, G., Gregorini, G., de Groot, K., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020286 · Cited by 1,348
Gresa-Arribas, N., Titulaer, M. J., Torrents, A., Aguilar, E., McCracken, L., Leypoldt, F., Gleichman, A. J., Balice-Gordon, R., Rosenfeld, M. R., Lynch, D., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70282-5 · Cited by 1,306
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis
Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., Parsons, T. D., Lynch, D. R., Dalmau, J., & Balice-Gordon, R. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0167-10.2010 · Cited by 1,143
Gultekin, S. H. (2000) · Brain · doi:10.1093/brain/123.7.1481 · Cited by 1,123
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
Koreth, J., Matsuoka, K.-I., Kim, H. T., McDonough, S. M., Bindra, B., Alyea, E. P., Armand, P., Cutler, C., Ho, V. T., Treister, N. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108188 · Cited by 1,119
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Liao, W., Lin, J.-X., & Leonard, W. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.01.004 · Cited by 1,075
Irani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035
Lancaster, E., Lai, M., Peng, X., Hughes, E., Constantinescu, R., Raizer, J., Friedman, D., Skeen, M. B., Grisold, W., Kimura, A., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70324-2 · Cited by 928
Paraneoplastic syndromes of the CNS
Dalmau, J., & Rosenfeld, M. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70060-7 · Cited by 873
Carson, K. R., Evens, A. M., Richey, E. A., Habermann, T. M., Focosi, D., Seymour, J. F., Laubach, J., Bawn, S. D., Gordon, L. I., Winter, J. N., et al. (2009) · Blood · doi:10.1182/blood-2008-10-186999 · Cited by 866
Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
Malek, T. R., & Castro, I. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.004 · Cited by 851
How corticosteroids control inflammation: Quintiles Prize Lecture 2005
Barnes, P. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706736 · Cited by 838
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location
Lai, M., Hughes, E. G., Peng, X., Zhou, L., Gleichman, A. J., Shu, H., Matà, S., Kremens, D., Vitaliani, R., Geschwind, M. D., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21589 · Cited by 813
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Buckner, J. H. (2010) · Nature Reviews Immunology · doi:10.1038/nri2889 · Cited by 789
Rother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A., & Bell, L. (2007) · Nature Biotechnology · doi:10.1038/nbt1344 · Cited by 778
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis
De Benedetti, F., Brunner, H. I., Ruperto, N., Kenwright, A., Wright, S., Calvo, I., Cuttica, R., Ravelli, A., Schneider, R., Woo, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112802 · Cited by 763
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
Saadoun, D., Rosenzwajg, M., Joly, F., Six, A., Carrat, F., Thibault, V., Sene, D., Cacoub, P., & Klatzmann, D. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105143 · Cited by 762
Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia
Lancaster, E., Huijbers, M. G. M., Bar, V., Boronat, A., Wong, A., Martinez‐Hernandez, E., Wilson, C., Jacobs, D., Lai, M., Walker, R. W., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22297 · Cited by 737
Gable, M. S., Sheriff, H., Dalmau, J., Tilley, D. H., & Glaser, C. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir1038 · Cited by 733
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis
Bien, C. G., Vincent, A., Barnett, M. H., Becker, A. J., Blumcke, I., Graus, F., Jellinger, K. A., Reuss, D. E., Ribalta, T., Schlegel, J., et al. (2012) · Brain · doi:10.1093/brain/aws082 · Cited by 695
Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up
van Sonderen, A., Thijs, R. D., Coenders, E. C., Jiskoot, L. C., Sanchez, E., de Bruijn, M. A. A. M., van Coevorden-Hameete, M. H., Wirtz, P. W., Schreurs, M. W. J., Sillevis Smitt, P. A. E., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003173 · Cited by 658
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
Klatzmann, D., & Abbas, A. K. (2015) · Nature Reviews Immunology · doi:10.1038/nri3823 · Cited by 636
Dalmau, J., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 628
Petit-Pedrol, M., Armangue, T., Peng, X., Bataller, L., Cellucci, T., Davis, R., McCracken, L., Martinez-Hernandez, E., Mason, W. P., Kruer, M. C., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70299-0 · Cited by 616
Gourley, M. F., Austin III, H. A., Scott, D., Yarboro, C. H., Vaughan, E. M., Muir, J., Boumpas, D. T., Klippel, J. H., Balow, J. E., & Steinberg, A. D. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00003 · Cited by 607
He, J., Zhang, X., Wei, Y., Sun, X., Chen, Y., Deng, J., Jin, Y., Gan, Y., Hu, X., Jia, R., et al. (2016) · Nature Medicine · doi:10.1038/nm.4148 · Cited by 572
Sabater, L., Gaig, C., Gelpi, E., Bataller, L., Lewerenz, J., Torres-Vega, E., Contreras, A., Giometto, B., Compta, Y., Embid, C., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70051-1 · Cited by 563
Morvan syndrome: Clinical and serological observations in 29 cases
Irani, S. R., Pettingill, P., Kleopa, K. A., Schiza, N., Waters, P., Mazia, C., Zuliani, L., Watanabe, O., Lang, B., Buckley, C., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23577 · Cited by 540
Carvajal-González, A., Leite, M. I., Waters, P., Woodhall, M., Coutinho, E., Balint, B., Lang, B., Pettingill, P., Carr, A., Sheerin, U.-M., et al. (2014) · Brain · doi:10.1093/brain/awu142 · Cited by 532
Overlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitis
Titulaer, M. J., Höftberger, R., Iizuka, T., Leypoldt, F., McCracken, L., Cellucci, T., Benson, L. A., Shu, H., Irioka, T., Hirano, M., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24117 · Cited by 518
Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal
Iizuka, T., Sakai, F., Ide, T., Monzen, T., Yoshii, S., Iigaya, M., Suzuki, K., Lynch, D. R., Suzuki, N., Hata, T., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000278388.90370.c3 · Cited by 517
Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis
Malter, M. P., Helmstaedter, C., Urbach, H., Vincent, A., & Bien, C. G. (2010) · Annals of Neurology · doi:10.1002/ana.21917 · Cited by 514
Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
Gelfand, E. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1009433 · Cited by 495
“LIMBIC ENCEPHALITIS” AND ITS ASSOCIATION WITH CARCINOMA
CORSELLIS, J. A. N., GOLDBERG, G. J., & NORTON, A. R. (1968) · Brain · doi:10.1093/brain/91.3.481 · Cited by 491
Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice
Planagumà, J., Leypoldt, F., Mannara, F., Gutiérrez-Cuesta, J., Martín-García, E., Aguilar, E., Titulaer, M. J., Petit-Pedrol, M., Jain, A., Balice-Gordon, R., et al. (2015) · Brain · doi:10.1093/brain/awu310 · Cited by 489
Encephalitis and GABA B receptor antibodies: Novel findings in a new case series of 20 patients
Höftberger, R., Titulaer, M. J., Sabater, L., Dome, B., Rózsás, A., Hegedus, B., Hoda, M. A., Laszlo, V., Ankersmit, H. J., Harms, L., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a9585f · Cited by 475
The clinical spectrum of Caspr2 antibody–associated disease
van Sonderen, A., Ariño, H., Petit-Pedrol, M., Leypoldt, F., Körtvélyessy, P., Wandinger, K.-P., Lancaster, E., Wirtz, P. W., Schreurs, M. W. J., Sillevis Smitt, P. A. E., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002917 · Cited by 441
The Diagnosis and Treatment of Autoimmune Encephalitis
Lancaster, E. (2016) · Journal of Clinical Neurology · doi:10.3988/jcn.2016.12.1.1 · Cited by 437
Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment
Rubenstein, J. L., Combs, D., Rosenberg, J., Levy, A., McDermott, M., Damon, L., Ignoffo, R., Aldape, K., Shen, A., Lee, D., et al. (2003) · Blood · doi:10.1182/blood-2002-06-1636 · Cited by 423
Extensive Immunoglobulin Production Sensitizes Myeloma Cells for Proteasome Inhibition
Meister, S., Schubert, U., Neubert, K., Herrmann, K., Burger, R., Gramatzki, M., Hahn, S., Schreiber, S., Wilhelm, S., Herrmann, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2258 · Cited by 410
Encephalitis and antibodies to synaptic and neuronal cell surface proteins
Lancaster, E., Martinez-Hernandez, E., & Dalmau, J. (2011) · Neurology · doi:10.1212/wnl.0b013e318224afde · Cited by 403
Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients
Höftberger, R., van Sonderen, A., Leypoldt, F., Houghton, D., Geschwind, M., Gelfand, J., Paredes, M., Sabater, L., Saiz, A., Titulaer, M. J., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001682 · Cited by 382
Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis
Martinez-Hernandez, E., Horvath, J., Shiloh-Malawsky, Y., Sangha, N., Martinez-Lage, M., & Dalmau, J. (2011) · Neurology · doi:10.1212/wnl.0b013e318228c136 · Cited by 375
Boronat, A., Gelfand, J. M., Gresa‐Arribas, N., Jeong, H., Walsh, M., Roberts, K., Martinez‐Hernandez, E., Rosenfeld, M. R., Balice‐Gordon, R., Graus, F., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23756 · Cited by 373
Acute mechanisms underlying antibody effects in anti–N‐methyl‐D‐aspartate receptor encephalitis
Moscato, E. H., Peng, X., Jain, A., Parsons, T. D., Dalmau, J., & Balice‐Gordon, R. J. (2014) · Annals of Neurology · doi:10.1002/ana.24195 · Cited by 367
Interleukin-6 as a Therapeutic Target
Rossi, J.-F., Lu, Z.-Y., Jourdan, M., & Klein, B. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2291 · Cited by 366
PROGRESSIVE ENCEPHALOMYELITIS, RIGIDITY, AND MYOCLONUS: A NOVEL GLYCINE RECEPTOR ANTIBODY
Hutchinson, M., Waters, P., McHugh, J., Gorman, G., O’Riordan, S., Connolly, S., Hager, H., Yu, P., Becker, C. M., & Vincent, A. (2008) · Neurology · doi:10.1212/01.wnl.0000327606.50322.f0 · Cited by 362
Tüzün, E., Zhou, L., Baehring, J. M., Bannykh, S., Rosenfeld, M. R., & Dalmau, J. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0582-4 · Cited by 360
Cognitive deficits following anti-NMDA receptor encephalitis
Finke, C., Kopp, U. A., Prüss, H., Dalmau, J., Wandinger, K.-P., & Ploner, C. J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300411 · Cited by 351
Anti-LGI1–associated cognitive impairment: Presentation and long-term outcome
Ariño, H., Armangué, T., Petit-Pedrol, M., Sabater, L., Martinez-Hernandez, E., Hara, M., Lancaster, E., Saiz, A., Dalmau, J., & Graus, F. (2016) · Neurology · doi:10.1212/wnl.0000000000003009 · Cited by 348
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease
Dale, R. C., Brilot, F., Duffy, L. V., Twilt, M., Waldman, A. T., Narula, S., Muscal, E., Deiva, K., Andersen, E., Eyre, M. R., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000570 · Cited by 344
Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis
Mikasova, L., De Rossi, P., Bouchet, D., Georges, F., Rogemond, V., Didelot, A., Meissirel, C., Honnorat, J., & Groc, L. (2012) · Brain · doi:10.1093/brain/aws092 · Cited by 341
Mihara, M., Kasutani, K., Okazaki, M., Nakamura, A., Kawai, S., Sugimoto, M., Matsumoto, Y., & Ohsugi, Y. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.05.010 · Cited by 328
A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder
Kim, S.-H., Huh, S.-Y., Lee, S. J., Joung, A., & Kim, H. J. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3071 · Cited by 324
Self-citationFinke, C., Prüss, H., Heine, J., Reuter, S., Kopp, U. A., Wegner, F., Then Bergh, F., Koch, S., Jansen, O., Münte, T., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4226 · Cited by 318
Altered B cell signalling in autoimmunity
Rawlings, D. J., Metzler, G., Wray-Dutra, M., & Jackson, S. W. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.24 · Cited by 308
Chronic stress and glucocorticoids: From neuronal plasticity to neurodegeneration
Vyas, S., Rodrigues, A. J., Silva, J. M., Tronche, F., Almeida, O. F. X., Sousa, N., & Sotiropoulos, I. (2016) · Neural Plasticity · doi:10.1155/2016/6391686 · Cited by 297
The mechanisms of action of plasma exchange
Reeves, H. M., & Winters, J. L. (2013) · British Journal of Haematology · doi:10.1111/bjh.12629 · Cited by 297
DPPX potassium channel antibody: Frequency, clinical accompaniments, and outcomes in 20 patients
Tobin, W. O., Lennon, V. A., Komorowski, L., Probst, C., Clardy, S. L., Aksamit, A. J., Appendino, J. P., Lucchinetti, C. F., Matsumoto, J. Y., Pittock, S. J., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000991 · Cited by 297
Kim, S.-H. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.154 · Cited by 295
Damato, V., Evoli, A., & Iorio, R. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.1637 · Cited by 290
Gleichman, A. J., Spruce, L. A., Dalmau, J., Seeholzer, S. H., & Lynch, D. R. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0064-12.2012 · Cited by 290
Kreye, J., Wenke, N. K., Chayka, M., Leubner, J., Murugan, R., Maier, N., Jurek, B., Ly, L.-T., Brandl, D., Rost, B. R., et al. (2016) · Brain · doi:10.1093/brain/aww208 · Cited by 290
SUBACUTE ENCEPHALITIS OF LATER ADULT LIFE. MAINLY AFFECTING THE LIMBIC AREAS
BRIERLEY, J. B., CORSELLIS, J. A. N., HIERONS, R., & NEVIN, S. (1960) · Brain · doi:10.1093/brain/83.3.357 · Cited by 285
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study
Araki, M., Matsuoka, T., Miyamoto, K., Kusunoki, S., Okamoto, T., Murata, M., Miyake, S., Aranami, T., & Yamamura, T. (2014) · Neurology · doi:10.1212/wnl.0000000000000317 · Cited by 284
Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study
Lee, W.-J., Lee, S.-T., Moon, J., Sunwoo, J.-S., Byun, J.-I., Lim, J.-A., Kim, T.-J., Shin, Y.-W., Lee, K.-J., Jun, J.-S., et al. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0442-6 · Cited by 271
Self-citationAnalysis of relapses in anti-NMDAR encephalitis
Gabilondo, I., Saiz, A., Galán, L., González, V., Jadraque, R., Sabater, L., Sans, A., Sempere, A., Vela, A., Villalobos, F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31822cfc6b · Cited by 264
Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases
Li, N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24394 · Cited by 264
Yu, A., Zhu, L., Altman, N. H., & Malek, T. R. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.014 · Cited by 263
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies
Papadopoulos, M. C., Bennett, J. L., & Verkman, A. S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.141 · Cited by 262
Ringelstein, M., Ayzenberg, I., Harmel, J., Lauenstein, A.-S., Lensch, E., Stögbauer, F., Hellwig, K., Ellrichmann, G., Stettner, M., Chan, A., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0533 · Cited by 242
Immune therapy in autoimmune encephalitis: a systematic review
Nosadini, M., Mohammad, S. S., Ramanathan, S., Brilot, F., & Dale, R. C. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1115720 · Cited by 239
Wiseman, A. C. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08570814 · Cited by 230
Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
Castela, E., Le Duff, F., Butori, C., Ticchioni, M., Hofman, P., Bahadoran, P., Lacour, J.-P., & Passeron, T. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.504 · Cited by 229
Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies
Ariño, H., Höftberger, R., Gresa-Arribas, N., Martínez-Hernández, E., Armangue, T., Kruer, M. C., Arpa, J., Domingo, J., Rojc, B., Bataller, L., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0749 · Cited by 229
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
Kowarik, M. C., Cepok, S., Sellner, J., Grummel, V., Weber, M. S., Korn, T., Berthele, A., & Hemmer, B. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-93 · Cited by 224
Regulatory T cell proliferative potential is impaired in human autoimmune disease
Carbone, F., De Rosa, V., Carrieri, P. B., Montella, S., Bruzzese, D., Porcellini, A., Procaccini, C., La Cava, A., & Matarese, G. (2014) · Nature Medicine · doi:10.1038/nm.3411 · Cited by 211
Plasma cells as an innovative target in autoimmune disease with renal manifestations
Hiepe, F., & Radbruch, A. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.20 · Cited by 209
Ayzenberg, I., Kleiter, I., Schröder, A., Hellwig, K., Chan, A., Yamamura, T., & Gold, R. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1246 · Cited by 206
Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis
Scheibe, F., Prüss, H., Mengel, A. M., Kohler, S., Nümann, A., Köhnlein, M., Ruprecht, K., Alexander, T., Hiepe, F., & Meisel, A. (2017) · Neurology · doi:10.1212/wnl.0000000000003536 · Cited by 203
Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder
Martinez-Hernandez, E., Ariño, H., McKeon, A., Iizuka, T., Titulaer, M. J., Simabukuro, M. M., Lancaster, E., Petit-Pedrol, M., Planagumà, J., Blanco, Y., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0133 · Cited by 198
Yu, A., Snowhite, I., Vendrame, F., Rosenzwajg, M., Klatzmann, D., Pugliese, A., & Malek, T. R. (2015) · Diabetes · doi:10.2337/db14-1322 · Cited by 197
Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort
Lee, W.-J., Lee, S.-T., Byun, J.-I., Sunwoo, J.-S., Kim, T.-J., Lim, J.-A., Moon, J., Lee, H. S., Shin, Y.-W., Lee, K.-J., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002635 · Cited by 195
Self-citationAntibodies to GABA A receptor α1 and γ2 subunits: Clinical and serologic characterization
Pettingill, P., Kramer, H. B., Coebergh, J. A., Pettingill, R., Maxwell, S., Nibber, A., Malaspina, A., Jacob, A., Irani, S. R., Buckley, C., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001326 · Cited by 183
Leypoldt, F., Höftberger, R., Titulaer, M. J., Armangue, T., Gresa-Arribas, N., Jahn, H., Rostásy, K., Schlumberger, W., Meyer, T., Wandinger, K.-P., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2956 · Cited by 183
Therapeutic uses of anti-interleukin-6 receptor antibody
Kang, S., Tanaka, T., & Kishimoto, T. (2015) · International Immunology · doi:10.1093/intimm/dxu081 · Cited by 170
The expanding field of IgG4‐mediated neurological autoimmune disorders
Huijbers, M. G., Querol, L. A., Niks, E. H., Plomp, J. J., van der Maarel, S. M., Graus, F., Dalmau, J., Illa, I., & Verschuuren, J. J. (2015) · European Journal of Neurology · doi:10.1111/ene.12758 · Cited by 167
Hansen, R., & Balthasar, J. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613331 · Cited by 164
Therapeutic approach to IgG4-related disease: A systematic review
Brito-Zerón, P., Kostov, B., Bosch, X., Acar-Denizli, N., Ramos-Casals, M., & Stone, J. H. (2016) · Medicine · doi:10.1097/md.0000000000004002 · Cited by 159
Autoimmune encephalitis: Recent updates and emerging challenges
Ramanathan, S., Mohammad, S. S., Brilot, F., & Dale, R. C. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.07.017 · Cited by 153
Type 1 Diabetes and Autoimmunity
Kawasaki, E. (2014) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.23.99 · Cited by 150
Kothur, K., Wienholt, L. A., Mohammad, S. S., Tantsis, E. M., Pillai, S. C., Britton, P. N., Jones, C., Angiti, R. R., Barnes, E. H., Schlub, T. E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161656 · Cited by 150
Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
Lang, B., Makuch, M., Moloney, T. C., Dettmann, I., Mindorf, S., Probst, C., Stoecker, W., Buckley, C. J., Newton, C. R. J. C., Leite, M. I., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314758 · Cited by 146
Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model
Wright, S. K., Hashemi, K. S., Stasiak, L., Bartram, J., Lang, B., Vincent, A. C., & Upton, A. L. (2015) · Brain · doi:10.1093/brain/awv257 · Cited by 142
Prednisone-induced alterations of circulating human lymphocyte subsets.
Slade, J., & Hepburn, B. (1983) · PubMed · Cited by 141
Anti– N -Methyl- d -Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care
de Montmollin, É., Demeret, S., Brule, N., Conrad, M., Dailler, F., Lerolle, N., Navellou, J.-C., Schwebel, C., Alves, M., Cour, M., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201603-0507oc · Cited by 141
Plasmapheresis in the critically ill patient.
Berlot, G., Tomasini, A., Silvestri, L., & Gullo, A. (1998) · PubMed · Cited by 140
The Laboratory Diagnosis of Autoimmune Encephalitis
Lee, S. K., & Lee, S. (2016) · Journal of Epilepsy Research · doi:10.14581/jer.16010 · Cited by 138
Self-citationFocal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis
Miller, T. D., Chong, T. T. ‐., Davies, A. M. A., Ng, T. W. C., Johnson, M. R., Irani, S. R., Vincent, A. C., Husain, M., Jacob, S., Maddison, P., et al. (2017) · Brain · doi:10.1093/brain/awx070 · Cited by 131
Tocilizumab in the treatment of rheumatoid arthritis and beyond
Sweiss, N., Shetty, A., Hanson, R. L., Korsten, P., Arami, S., Volkov, S., Vila, O. M., Swedler, W. I., Shahrara, S., Smadi, S., et al. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s41437 · Cited by 130
Invited Article: Inhibition of B cell functions
Dalakas, M. C. (2008) · Neurology · doi:10.1212/01.wnl.0000313840.27060.bf · Cited by 119
Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study
Iizuka, T., Yoshii, S., Kan, S., Hamada, J., Dalmau, J. O., Sakai, F., & Mochizuki, H. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5604-6 · Cited by 116
CSF findings in patients with anti-N-methyl-d-aspartate receptor-encephalitis
Wang, R., Guan, H., Ren, H., Wang, W., Hong, Z., & Zhou, D. (2015) · Seizure · doi:10.1016/j.seizure.2015.04.005 · Cited by 107
NMDA RECEPTOR ENCEPHALITIS MIMICKING SERONEGATIVE NEUROMYELITIS OPTICA
Kruer, M. C., Koch, T., BOURDETTE, D. N., Chabas, D., Waubant, E. L., Mueller, S. G., Moscarello, M. A., Dalmau, J. O., Woltjer, R. L., & Adamus, G. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dc1a7f · Cited by 104
Immunoadsorption therapy in autoimmune encephalitides
Onugoren, M. D., Golombeck, K. S., Bien, C., Abu-Tair, M., Brand, M., Bulla-Hellwig, M., Lohmann, H., Münstermann, D., Pavenstädt, H. J., Thölking, G., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000207 · Cited by 103
Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study
Heine, J., Ly, L.-T., Lieker, I., Slowinski, T., Finke, C., Prüß, H., & Harms, L. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8277-y · Cited by 100
Iizuka, T., Kaneko, J., Tominaga, N., Someko, H., Nakamura, M., Ishima, D., Kitamura, E., Masuda, R., Oguni, E., Yanagisawa, T., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0232 · Cited by 99
Crisp, S. J., Kullmann, D. M., & Vincent, A. C. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2015.27 · Cited by 98
Practical considerations on the use of rituximab in autoimmune neurological disorders
Kosmidis, M. L., & Dalakas, M. C. (2010) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609356135 · Cited by 95
Plasma exchange in pediatric anti-NMDAR encephalitis: A systematic review
Suppiej, A., Nosadini, M., Zuliani, L., Pelizza, M. F., Toldo, I., Bertossi, C., Tison, T., Zoccarato, M., Marson, P., Giometto, B., et al. (2016) · Brain and Development · doi:10.1016/j.braindev.2016.01.009 · Cited by 92
Byun, J., Lee, S., Jung, K., Sunwoo, J., Moon, J., Lim, J., Lee, D. Y., Shin, Y., Kim, T., Lee, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146455 · Cited by 88
Self-citationDeSena, A. D., Noland, D. K., Matevosyan, K., King, K., Phillips, L. T., Qureshi, S. S., Greenberg, B. M., & Graves, D. F. (2015) · Journal of Clinical Apheresis · doi:10.1002/jca.21363 · Cited by 83
Bortezomib Treatment for Patients With Anti-N-Methyl- d -Aspartate Receptor Encephalitis
Behrendt, V., Krogias, C., Reinacher‐Schick, A., Gold, R., & Kleiter, I. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2588 · Cited by 81
Steroids and the Blood–Brain Barrier
WITT, K. A., & Sandoval, K. E. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.06.018 · Cited by 80
Re-establishing immunological self-tolerance in autoimmune disease
Sakaguchi, S., Powrie, F. M., & Ransohoff, R. M. (2012) · Nature Medicine · doi:10.1038/nm.2622 · Cited by 79
Hansen, H.-C., Klingbeil, C., Dalmau, J. O., Li, W., Weißbrich, B., & Wandinger, K. (2012) · JAMA Neurology · doi:10.1001/jamaneurol.2013.585 · Cited by 79
Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies
Jacob, S., & Rajabally, Y. A. (2009) · Current Neuropharmacology · doi:10.2174/157015909790031166 · Cited by 79
McKeon, G. L., Scott, J. G., Spooner, D., Ryan, A. E., Blum, S., Gillis, D., Langguth, D., & Robinson, G. A. (2016) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617716000679 · Cited by 74
Maintenance immunosuppression in myasthenia gravis
Feldman, L. M., & Li, Y. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.08.057 · Cited by 72
Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma.
Lahood, N., Emerson, S. S., Kumar, P., & Sorensen, R. (1993) · PubMed · Cited by 65
Constantinescu, R., Krýsl, D., Bergquist, F., Andrén, K., Malmeström, C., Asztély, F., Axelsson, M., Menachem, E. B., Blennow, K., Rosengren, L., et al. (2016) · European Journal of Neurology · doi:10.1111/ene.12942 · Cited by 59
Natural course of LGI1 encephalitis: 3–5years of follow-up without immunotherapy
Szőts, M., Marton, A., Kövér, F., Kiss, T., Berki, T., Nagy, F., & Illés, Z. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.05.048 · Cited by 57
Restoring immune tolerance in neuromyelitis optica: Part II
Bar‐Or, A., Steinman, L., Behne, J. M., Benítez‐Ribas, D., Chin, P. S., Clare-Salzler, M. J., Healey, D. G., Kim, J. I., Kranz, D. M., Lutterotti, A., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000277 · Cited by 57
Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system
Melzer, N., Meuth, S. G., & Wiendl, H. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6657-5 · Cited by 55
New feasible treatment for refractory autoimmune encephalitis: Low-dose interleukin-2
Lim, J., Lee, S., Moon, J., Jun, J., Park, B.-S., Byun, J., Sunwoo, J., Park, K., Jung, K., Jung, K., et al. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.09.001 · Cited by 55
Self-citationvan Coevorden‐Hameete, M. H., Titulaer, M. J., Schreurs, M. W. J., de Graaff, E., Smitt, P. A. E. S., & Hoogenraad, C. C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00037 · Cited by 51
Klingel, R., Heibges, A., & Fassbender, C. (2009) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(09)71827-6 · Cited by 44
Restoring immune tolerance in neuromyelitis optica: Part I
Steinman, L., Bar‐Or, A., Behne, J. M., Benítez‐Ribas, D., Chin, P. S., Clare-Salzler, M. J., Healey, D. G., Kim, J. I., Kranz, D. M., Lutterotti, A., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000276 · Cited by 43
Fleischmann, R., Prüß, H., Rosche, B., Bahnemann, M., Gelderblom, H., Deuschle, K., Harms, L., Kopp, U. A., & Ruprecht, K. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1817 · Cited by 40
Tryptophan immunoadsorption for the treatment of autoimmune encephalitis
Köhler, W., Ehrlich, S., Dohmen, C., Haubitz, M., Hoffmann, F. A., Schmidt, S., Klingel, R., Kraft, A., Neumann‐Haefelin, T., Topka, H. R., et al. (2014) · European Journal of Neurology · doi:10.1111/ene.12389 · Cited by 40
Prevalence and treatment of anti-NMDA receptor encephalitis – Authors' reply
Titulaer, M. J., Kayser, M. S., & Dalmau, J. O. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70072-3 · Cited by 37
Neuronal central nervous system syndromes probably mediated by autoantibodies
Chefdeville, A., Honnorat, J., Hampe, C. S., & Desestret, V. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13212 · Cited by 35
Martin, S. T., Cardwell, S. M., Nailor, M. D., & Gabardi, S. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12649 · Cited by 34
Kim, S. Y., Choi, S. A., Ryu, H. W., Kim, H., Lim, B. C., Hwang, H. Y., Chae, J., Choi, J., Kim, K. J., Hwang, Y. S., et al. (2014) · Journal of Epilepsy Research · doi:10.14581/jer.14012 · Cited by 30
Self-citationHickman, L. C., Valentine, L. N., & Falcone, T. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.06.053 · Cited by 30
GAD65 as a prototypic autoantigen
Fenalti, G., & Rowley, M. J. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.04.013 · Cited by 27
Uzawa, A., Mori, M., Takahashi, Y., Ogawa, Y., Uchiyama, T., & Kuwabara, S. (2011) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.10.047 · Cited by 27
Iro, M. A., Sadarangani, M., Absoud, M., Chong, W. K., Clark, C., Easton, A., Gray, V., Kneen, R., Lim, M. J., Pike, M. G., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012356 · Cited by 21
Byun, J., Lee, S., Jung, K., Sunwoo, J., Moon, J., Kim, T., Lim, J., Kim, S., Kim, D.-Y., Han, S., et al. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.02.002 · Cited by 14
Self-citation
Cited by
Development of the clinical assessment scale in autoimmune encephalitis
Lim, J., Lee, S., Moon, J., Jun, J., Kim, T., Shin, Y., Abdullah, S., Byun, J., Sunwoo, J., Kim, K. T., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25421 · Cited by 253
Self-citationWesselingh, R., Butzkueven, H., Buzzard, K., Tarlinton, D., O'Brien, T. J., & Monif, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02066 · Cited by 83
“In patients with relapsing or refractory disease, longer term “maintenance” treatment with mycophenolate mofetil, azathioprine, ciclosporin or methotrexate has been used (85).”
Background
Metadata
- Authors
- Shin, Y.-W., Lee, S.-T., Park, K.-I., Jung, K.-H., Jung, K.-Y., Lee, S. K., & Chu, K.
- Venue
- Therapeutic Advances in Neurological Disorders
- Publisher
- SAGE Publications
- Published
- 2017-08-16
- Volume
- 11
- Pages
- 1756285617722347-1756285617722347
- ISSN
- 1756-2856 (ISSN-L)
- 1756-2864
- OpenAlex
- W2745764093
- Cited by
- 266
- References
- 147
- FWCI
- 13.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.